Grégory Lambert

Chief Executive Officer at TargEDys SA

Health Technology

Profile

Grégory Lambert is currently the Chief Executive Officer, Director, and VP-R&D at TargEDys SA since 2014.
Prior to his current position, he worked as the Vice President of Research & Development at Novagali Pharma SA.

Grégory Lambert active positions

Companies	Position	Start
TargEDys SA TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.	Chief Executive Officer	01/01/2014

All active positions of Grégory Lambert

Former positions of Grégory Lambert

Companies	Position	End
Novagali Pharma SA Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France.	Chief Tech/Sci/R&D Officer	-

See the detail of Grégory Lambert's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Grégory Lambert's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Novagali Pharma SA Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France.	Health Technology
TargEDys SA TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.	Health Technology